MDxHealth affirms FY2026 sales guidance at $110.0M–$115.0M
MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate.
MDxHealth (NASDAQ: MDXH ) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.000 million-$115.000 million vs $98.814 million estimate.